Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk and Prognosis of Brain Metastasis in Non-Small Cell Lung Cancer: A Multicenter, Prospective, Observational Study

NCT07034365 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07034365
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07034365 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk and Prognosis of Brain Metastasis in Non-Small Cell Lung Cancer: A Multicenter, Prospective, Observational Study
Lead sponsor
Fudan University
Phase
Observational
Overall status
Not yet recruiting
Start date
August 31, 2025
Completion date
May 31, 2027
Enrollment
2,000 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

brain metastases from non-small cell lung cancer (nsclc), nsclc (non-small cell lung cancer)